The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

For cell therapy, they help engineer immune cells like CAR-T cells to fight cancer. Gene editing tools like CRISPR/Cas ... Casgevy enables CRISPR/Cas-9 to edit the BCL11A gene in stem cells to produce ...

For cell therapy, they help engineer immune cells like CAR-T cells to fight cancer. Gene editing tools ... Casgevy enables CRISPR/Cas-9 to edit the BCL11A gene in stem cells to produce fetal ...

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the ...

This causes BCL11A to not be made which in turn allows gamma globin ... therapy – involving adding genes to our DNA – have been associated with induction of cancer and so the field is naturally ...

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...

While there currently isn’t a cure for cancer, researchers are exploring several new treatments, including vaccines and gene editing, that could eventually change the face of cancer treatment.